Angiotensin II type-1 receptor A1166C polymorphism is associated with increased risk of ischemic stroke in hypertensive smokers

Journal of Molecular Neuroscience

Volumn 28, Issue 3, 2006, Pages 285-290

  Szolnoki, Zoltán ^a   Havasi, Viktória ^b   Talián, Gábor ^b   Bene, Judit ^b   Komlósi, Katalin ^b   Somogyvári, Ferenc ^a,c   Kondacs, András ^a   Szabó, Mihály ^a   Fodor, Lajos ^a   Bodor, Anita ^d   Melegh, Béla ^b  

^a Pandy Kalman County Hospital   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Rethy Pal Hospital   (Hungary)

Author keywords

AT1R A1166C polymorphism; Genetic interaction; Stroke risk

Indexed keywords

ANGIOTENSIN 2 RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BLOOD VESSEL DIAMETER; CARDIOPULMONARY INSUFFICIENCY; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; INFARCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; RECEPTOR UPREGULATION; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS;

ADULT; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RISK FACTORS; SMOKING; STROKE;

EID: 33646880646     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:28:3:285     Document Type: Article

References (25)

1. Agachan B., Isbir T., Yilmaz H., and Akoglu E. (2003) Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp. Mol. Med. 35, 545-549.
2. Cheng Z. J., Vapaatalo H., and Mervaala E. (2005) Angiotensin II and vascular inflammation. Med. Sci. Monit. 25, 194-205.
3. Ferreira A. J. and Santos R. A. S. (2005) Cardiovascular action of angiotensin (1-7). Braz. J. Med. Biol. Res. 38, 499-507.
4. Fukazawa R., Sonobe T., Hamamato K., Hamaoka K., Sakata K., Asano T., et al. (2004) Possible synergic effect of angiotensin-I converting enzyme insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischaemic heart disease in patients with Kawasaki disease. Pediatr. Res. 56, 597-601.
5. Henderson S. O., Haiman C. A., and Mack W. (2004) Multiple polymorphisms in the renin-angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethnic cohort. Am. J. Med. Sci. 328, 266-273.
6. Hindorff L. A., Heckbert S. R., Tracy R., Tang Z., Psaty B. M., Edwards K. I., et al. (2002) Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am. J. Hypertens. 15, 1050-1056.
7. Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., et al. (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112-116.
8. Jones A., Dhamrait S. S., Payne J. R., Hawe E., Li P., Toor I. S., et al. (2003) Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 42, 500-506.
9. Kobashi G., Hata A., Ohta K., Yamada H., Kato E. H., Minakami H., et al. (2004) A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene. J. Hum. Genet. 49, 182-186.
10. Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., et al. (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11, 875-879.
11. Miller J. A. and Scholey J. W. (2004) The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr. Opin. Nephrol. Hypertens. 13, 101-106.
12. Miller S. A., Dykes D. D., and Polesky H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215-1218.
13. Munzel T., Daiber A., Ullrich V., and Mulsch A. (2005) Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler. Thromb. Vasc. Biol. 25, 1551-1557.
14. Nicholls J. and Peiris M. (2005) Good ACE, bad ACE do battle in lung injury SARS. Nat. Med. 11, 821-822.
15. Rubattu S., DiAngelantonio E., Stanzione R., Zanda B., Evangelista A., Pirisi A., et al. (2004) Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J. Hypertens. 22, 2129-2134.
16. Sainani G. S. and Maru V. G. (2004) Role of endothelial cell dysfunction in essential hypertension. J. Assoc. Physicians India 52, 966-969.
17. Schmieder R. E. (2005) Mechanisms for the clinical benefits of angiotensin II receptor blockers. Am. J. Hypertens. 18, 720-730.
18. Schram M. T. and Stehouwer C. D. (2005) Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm. Metab. Res. 37, 49-55.
19. Sugimoto K., Katsuya T., Ohkubo T., Hozawa A., Yamamoto K., Matsuo A., et al. (2004) Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens. Res. 27, 551-556.
20. Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., and Fodor L. (2002) Evaluation of the interactions of common genetic mutations in stroke subtypes. J. Neurol. 249, 1391-1397.
21. Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., Fodor L., Bene J., and Melegh B. (2003) Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 74, 1615-1620.
22. Treszl A., Szabo M., Dunai G., Nobilis A., Kocsis I., Machay T., et al. (2003) Angiotensin II type 1 receptor, a 1166C polymorphism and prophylactic indomethacin treatment induced ductus arterious closure in very low birth weight neonates. Pediatr. Res. 54, 753-755.
23. Um J. Y., Moon K. S., Lee K. M., Cho K. H., Heo Y., Moon B. S., and Kim H. M. (2003) Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infaction. J. Mol. Neurosci. 21, 23-28.
24. van Geel P. P., Pinto Y. M., Voors A. A., Buikema H., Oosterga M., Crijns H. J. G. M., and van Gilst W. H. (2000) Angiotenin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35, 717-721.
25. World Health Organization (1985) Report on diabetes mellitus. World Health Organ. Tech. Rep. Ser. 727.